| Overall | 2008a | 2008–2009 | 2009–2010 | 2010–2011 | 2011–2012 | 2012–2013 | 2013–2014 | 2014–2015 |
---|---|---|---|---|---|---|---|---|---|
Passively detected cases | |||||||||
 Number | 46 | – | – | – | – | – | 12 | 25 | 9 |
 Age in years (median [IQR]) | 13 [7–30] | – | – | – | – | – | 11 [7–30] | 18 [9–32] | 11 [7–11] |
 Male (%) | 64.4 | – | – | – | – | – | 63.64 | 60.00 | 77.78 |
Actively detected cases | |||||||||
Number | 72 | 15 | 19 | 13 | 12 | 7 | 6 | ||
 Age in years (median [IQR]) | 14 [11–21] | 14 [9–18] | 13 [11–18] | 17 [11–20] | 14.5 [10.5–24] | 25 [13–31] | 12.5 [6–47] | ||
 Male (%) | 55.6 | 66.7 | 52.6 | 53.9 | 50.0 | 57.1 | 50.0 | ||
 Symptomatic (%) | 34.7 | 60.0 | 15.8 | 23.1 | 16.7 | 57.1 | 66.7 | ||
 Microscopy positive (%) | 11.1 | 35.0 | 7.1 | 11.1 | 0.0 | 25.0 | 0.0 | ||
 RDT positive (%) | 20.8 | 20.0 | 31.6 | 23.1 | 8.3 | 14.3 | 16.7 |